Full text
PDFPage 1506
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Byrne E. J., Arie T. Tetrahydroaminoacridine and Alzheimer's disease. BMJ. 1994 Apr 2;308(6933):868–869. doi: 10.1136/bmj.308.6933.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ford J. M., Truman C. A., Wilcock G. K., Roberts C. J. Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease. Clin Pharmacol Ther. 1993 Jun;53(6):691–695. doi: 10.1038/clpt.1993.91. [DOI] [PubMed] [Google Scholar]
- Maltby N., Broe G. A., Creasey H., Jorm A. F., Christensen H., Brooks W. S. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial. BMJ. 1994 Apr 2;308(6933):879–883. doi: 10.1136/bmj.308.6933.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilcock G. K., Surmon D. J., Scott M., Boyle M., Mulligan K., Neubauer K. A., O'Neill D., Royston V. H. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease. Age Ageing. 1993 Sep;22(5):316–324. doi: 10.1093/ageing/22.5.316. [DOI] [PubMed] [Google Scholar]